| 证券代码 | CERCW.O |
| 证券名称 | Cerecor Inc Wt-A |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2015-11-13 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Avalo Therapeutics, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 400 E. Pratt Street, Suite 606, Baltimore, Maryland, USA |
| 成立日期 | 2011-01-31 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.cerecor.com |
| 电话 | +1 (410) 522-8707 |
| 传真 | - |
| 公司简介 | Avalo Therapeutics, Inc. (former name: Cerecor Inc.) is a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders. It systematically identify platforms and product candidates for which human proof of concept exists in the intended indication, for either the target or the compound, and for which biomarkers are available to measure therapeutic response. |